WELLS FARGO & COMPANY/MN - TALIS BIOMEDICAL CORP ownership

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$84
+2.4%
174
+4.2%
0.00%
Q1 2023$82
+12.3%
167
+1.8%
0.00%
Q4 2022$73164
+3.1%
0.00%
Q3 2022$0159
+51.4%
0.00%
Q2 2022$0
-100.0%
105
-96.6%
0.00%
Q1 2022$4,000
-87.5%
3,072
-61.7%
0.00%
Q4 2021$32,000
-85.2%
8,023
-59.0%
0.00%
Q2 2021$216,000
+307.5%
19,557
+372.6%
0.00%
Q1 2021$53,0004,1380.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,073,1760.05%
WELLS FARGO & COMPANY/MN 174$840.00%
NORTHERN TRUST CORP 27,860$13,3730.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 140,530$67,4540.00%
STATE STREET CORP 47,436$22,7690.00%
MILLENNIUM MANAGEMENT LLC 91,463$43,9020.00%
DEUTSCHE BANK AG\ 45,294$21,7410.00%
MORGAN STANLEY 61,857$29,6910.00%
BlackRock Inc. 76,307$36,6280.00%
View complete list of TALIS BIOMEDICAL CORP shareholders